ELEVATE-RR – first head-to-head trial of acalabrutinib versus ibrutinib in previously treated high risk chronic lymphocytic leukemia

par Tatiana E. Bialik, Vladimir I. Vorob'ev, Valerii A. Ionin, Loic Ysebaert, Kamil D. Kaplanov, Larisa P. Mendeleeva, Evgenii A. Nikitin, Vadim V. Ptushkin, Olga S. Samoilova, Elena A. Stadnik
Publié 2021

Multiple myeloma

par Larisa P. Mendeleeva, Olga M. Votiakova, Irina G. Rekhtina, Evgenii A. Osmanov, Irina V. Poddubnaya, Liudmila Iu. Grivtsova, Natalia A. Falaleeva, Vadim V. Baikov, Alla M. Kovrigina, Aleksei A. Nevol’skikh, Sergei A. Ivanov, Zhanna V. Khailova, Tigran G. Gevorkian
Publié 2021